Ye Qin

Education

2022.08.01-now: Research Assistant, Molecular Imaging Center, Shanghai Institute of Materia Medica, CAS, Shanghai, P.R. China

2016.07-2019.12: Post-doctor, Women’s Cancer Research Center, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA

2014.07-2022.07: Lecturer/Associate Professor, Medical College, China Three Gorges University, Yichang, P.R. China

2011.09-2014.07: Doctor of Medicine (M.D.), Institute of Medical Biotechnology, Chinese Academy of Medical Science and Peking Union Medical College (PUMC), Beijing, P.R. China

2008.09-2011.06: Master of Science (M.Sc.), Molecular Immunology, China Three Gorges University, Yichang, P.R. China

2003.09-2008.06: Bachelor of Medicine (M.B.), Medical College, China Three Gorges University, Yichang, P.R. China

Research Directions

Tumor metastasis mechanism, molecular imaging diagnosis and treatment

Research Interests

Molecular Imaging, petrochemical industry

Grants & Research Projects

  1. National Natural Science Foundation of China (81502366)
  2. Key project of Science and Technology Research Program of Hubei Provincial Department of Education (2266716)
  3. Hubei Provincial Key Laboratory of Tumor Microenvironment and Immunotherapy (China Three Gorges University) (2020KZL01)
  4. Talent Research Start-up Fund of China Three Gorges University (KJ2014B068）

 

Publications

  1. Feifei HuA, Ye QinA, Yiqing ZhouA, et al. Characterization of precipitation from citrus vinegar during ageing: Chemical constituents, formation mechanism and anti-proliferative effect. Food & Function, 2022, 13(9):4930-4940.
  2. Ye QinA, Shan LiuA, Qun ZouA, et al. Napthoquinones from Catalpa bungei “Jinsi” as potent antiproliferation agents inducing DNA damage. Fitoterapia, 2022, doi: 10.1016/j.fitote.2022.105196.
  3. Lingyue Li, Yiyu Wang, …, Ye Qin. KDM1A identified as a potential oncogenic driver and prognostic biomarker via multi-omics analysis. Canadian Journal of Infectious Diseases and Medical Microbiology, 2021, doi: 1155/2021/4668565.
  4. Ye Qin, Shauna N. Vasilatos, Lin Chen, et al. Inhibition of histone lysine-specific demethylase1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade. Oncogene, 2019, 38:390-405.
  5. Mulan Wei, Xujie Liu…Ye Qin. An engineered PD-1-based and MMP-2/9-oriented fusion protein exerts potent antitumor effects against melanoma. BMB reports, 2018, 51(11): 572-577.
  6. Lin Chen, Shauna N. Vasilatos, Ye Qin, et al. Functional characterization of lysine-specific demethylase 2 (LSD2/KDM1B) in breast cancer progression. Oncotarget, 2017,8(47):81737-81753.
  7. Ye QinA, Jianlin YangA, Liang Li, et al. Apoptotic melanoma B16-F1 cells induced by lidamycin could initiate the antitumor immune response in BABL/c mice. Oncology Research, 2016, 23:79-86.
  8. Ye Qin, Xiu-jun Liu, Liang Li, et al. MMP-2/9-oriented combinations escalate antitumor efficacy of the EGFR/HER2- targeting fusion proteins and gemcitabine. Oncol Rep, 2014, 32(1):121-130.
  9. Wu HY, Han Y, Qin Y, et al. Whole-cell vaccine coeted with recombinant calreticulin enhances activation of dendritic cells and induces tumour-specific immune responses. Oncology Reports, 2013, 29: 529-534.
  10. Ye Qin, Yu Han, Chunyu Cao, et al. Melanoma B16-F1 cells coated with fusion protein of mouse calreticulin and virus G-protein coupled receptor induced the antitumor immune response in Balb/C mice. Cancer Biology & Therapy, 2011, 11(6): 574-580.
  11. Chunyu Cao, Yu Han,Ye Qin, Yanlin Wang. Apoptotic B16-F1 Cells Coated with Recombinant Calreticulin Mediated Anti-tumor Immune Response in Mice. Chinese J Cancer Research, 22(4):253-259, 2010.

 

Contact Information

Molecular Imaging Center

Shanghai Institute of Materia Medica

China Academy of Sciences

4th Floor, Building 3, 647 Songtao Road, Zhang Jiang Hi-Tech Park

Pudong, Shanghai, 201203, P.R. China

Email: ycqinye@163.com